Literature DB >> 26586579

Diagnostic accuracy and clinical relevance of an inflammatory biomarker panel for sepsis in adult critically ill patients.

Philippe R Bauer1, Rahul Kashyap2, Stacy C League3, John G Park4, Darci R Block5, Nikola A Baumann6, Alicia Algeciras-Schimnich7, Sarah M Jenkins8, Carin Y Smith9, Ognjen Gajic10, Roshini S Abraham11.   

Abstract

The objective of this study was to assess the diagnostic accuracy of C-reactive protein (CRP), procalcitonin (PCT), and cellular immune markers levels in sepsis. This was a prospective observational study in adult intensive care unit (ICU) patients, between 2012 and 2014. The 8-color flow cytometric biomarker panel included CD64, CD163, and HLA-DR. Index test results were compared with sepsis, using receiver operating characteristic curve analyses. Multivariate logistic regression assessed the relationship of sets of markers with the probability of sepsis. Of 219 enrolled patients, 120 had sepsis. C-statistic was the highest for CRP (0.86) followed by neutrophil CD64 expression (0.83), procalcitonin (0.82), and Acute Physiology and Chronic Health Evaluation (APACHE) IV (0.72). After adjustment for APACHE IV, the combination of CRP, PCT, and neutrophil CD64 measure remained a significant predictor of sepsis with an excellent AUC (0.90). In a targeted ICU population at increased risk of sepsis, CRP, PCT, and neutrophil CD64 combined improve the diagnostic accuracy of sepsis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C-reactive protein; CD64; Procalcitonin; Sensitivity and specificity; Sepsis; Study of diagnostic accuracy

Mesh:

Substances:

Year:  2015        PMID: 26586579      PMCID: PMC4716883          DOI: 10.1016/j.diagmicrobio.2015.10.003

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  40 in total

Review 1.  Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy.

Authors:  Hanne Van Gorp; Peter L Delputte; Hans J Nauwynck
Journal:  Mol Immunol       Date:  2010-03-17       Impact factor: 4.407

2.  Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis.

Authors:  P Cardelli; M Ferraironi; R Amodeo; F Tabacco; R A De Blasi; M Nicoletti; R Sessa; A Petrucca; A Costante; P Cipriani
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Jan-Mar       Impact factor: 3.219

3.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

4.  The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria.

Authors:  Babs O Fabriek; Robin van Bruggen; Dong Mei Deng; Antoon J M Ligtenberg; Kamran Nazmi; Karin Schornagel; Rianka P M Vloet; Christine D Dijkstra; Timo K van den Berg
Journal:  Blood       Date:  2008-10-10       Impact factor: 22.113

5.  Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock.

Authors:  Guillaume Monneret; Alain Lepape; Nicolas Voirin; Julien Bohé; Fabienne Venet; Anne-Lise Debard; Hélène Thizy; Jacques Bienvenu; François Gueyffier; Philippe Vanhems
Journal:  Intensive Care Med       Date:  2006-06-02       Impact factor: 17.440

6.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

7.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial.

Authors:  Lila Bouadma; Charles-Edouard Luyt; Florence Tubach; Christophe Cracco; Antonio Alvarez; Carole Schwebel; Frédérique Schortgen; Sigismond Lasocki; Benoît Veber; Monique Dehoux; Maguy Bernard; Blandine Pasquet; Bernard Régnier; Christian Brun-Buisson; Jean Chastre; Michel Wolff
Journal:  Lancet       Date:  2010-01-25       Impact factor: 79.321

8.  CD64 index provides simple and predictive testing for detection and monitoring of sepsis and bacterial infection in hospital patients.

Authors:  M Icardi; Y Erickson; S Kilborn; B Stewart; B Grief; G Scharnweber
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

9.  Neutrophil CD64 expression and serum IL-8: sensitive early markers of severity and outcome in sepsis.

Authors:  Olga Livaditi; Anastasia Kotanidou; Aikaterini Psarra; Ioanna Dimopoulou; Christina Sotiropoulou; Kallirroi Augustatou; Chryssa Papasteriades; Apostolos Armaganidis; Charis Roussos; Stylianos E Orfanos; Emmanuel E Douzinas
Journal:  Cytokine       Date:  2007-03-26       Impact factor: 3.861

10.  Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression.

Authors:  D D Danikas; M Karakantza; G L Theodorou; G C Sakellaropoulos; C A Gogos
Journal:  Clin Exp Immunol       Date:  2008-08-22       Impact factor: 4.330

View more
  8 in total

1.  A community approach to mortality prediction in sepsis via gene expression analysis.

Authors:  Timothy E Sweeney; Thanneer M Perumal; Ricardo Henao; Marshall Nichols; Judith A Howrylak; Augustine M Choi; Jesús F Bermejo-Martin; Raquel Almansa; Eduardo Tamayo; Emma E Davenport; Katie L Burnham; Charles J Hinds; Julian C Knight; Christopher W Woods; Stephen F Kingsmore; Geoffrey S Ginsburg; Hector R Wong; Grant P Parnell; Benjamin Tang; Lyle L Moldawer; Frederick E Moore; Larsson Omberg; Purvesh Khatri; Ephraim L Tsalik; Lara M Mangravite; Raymond J Langley
Journal:  Nat Commun       Date:  2018-02-15       Impact factor: 14.919

2.  Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis.

Authors:  Yutaka Kondo; Yutaka Umemura; Kei Hayashida; Yoshitaka Hara; Morio Aihara; Kazuma Yamakawa
Journal:  J Intensive Care       Date:  2019-04-15

Review 3.  Flow Cytometry of CD64, HLA-DR, CD25, and TLRs for Diagnosis and Prognosis of Sepsis in Critically Ill Patients Admitted to the Intensive Care Unit: A Review Article.

Authors:  Ata Mahmoodpoor; Seyedpouya Paknezhad; Kamran Shadvar; Hadi Hamishehkar; Ali Akbar Movassaghpour; Sarvin Sanaie; Ali Akbar Ghamari; Hassan Soleimanpour
Journal:  Anesth Pain Med       Date:  2018-12-05

Review 4.  Biomarkers for Point-of-Care Diagnosis of Sepsis.

Authors:  Andrew Teggert; Harish Datta; Zulfiqur Ali
Journal:  Micromachines (Basel)       Date:  2020-03-10       Impact factor: 2.891

5.  Diagnostic value of neutrophil CD64, procalcitonin, and interleukin-6 in sepsis: a meta-analysis.

Authors:  Shan Cong; Tiangang Ma; Xin Di; Chang Tian; Min Zhao; Ke Wang
Journal:  BMC Infect Dis       Date:  2021-04-26       Impact factor: 3.090

6.  Machine learning identification of specific changes in myeloid cell phenotype during bloodstream infections.

Authors:  Christian Gosset; Jacques Foguenne; Mickaël Simul; Olivier Tomsin; Hayet Ammar; Nathalie Layios; Paul B Massion; Pierre Damas; André Gothot
Journal:  Sci Rep       Date:  2021-10-13       Impact factor: 4.379

7.  Correlation of Neutrophil CD64 with Clinical Profile and Outcome of Sepsis Patients during Intensive Care Unit Stay.

Authors:  Pralay Shankar Ghosh; Harshit Singh; Afzal Azim; Vikas Agarwal; Saurabh Chaturvedi; Sai Saran; Prabhaker Mishra; Mohan Gurjar; Arvind Kumar Baronia; Banani Poddar; Ratender Kumar Singh; Ravi Mishra
Journal:  Indian J Crit Care Med       Date:  2018-08

Review 8.  A 2020 review on the role of procalcitonin in different clinical settings: an update conducted with the tools of the Evidence Based Laboratory Medicine.

Authors:  Anna Maria Azzini; Romolo Marco Dorizzi; Piersandro Sette; Marta Vecchi; Ilaria Coledan; Elda Righi; Evelina Tacconelli
Journal:  Ann Transl Med       Date:  2020-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.